GLP-1 Foods: What Raises It and What to Eat

GLP-1 foods are real, but the effect is small and short. Whey protein before a meal raised intact GLP-1 by 298% in a crossover trial¹, and eating carbohydrate last raised it by about a third². Your own GLP-1 is broken down within minutes³, while semaglutide lasts about 1 week in the blood⁴, so no food copies the drug.

Food still matters on both sides of the question. Meal order, protein and fermentable fiber shape how full you feel and how high your blood sugar rises, and on a GLP-1 drug the priority shifts to protein, fluids and small, low-fat meals^{5, 6}. For the wider picture, see our weight management hub and the obesity evidence page.

Yes, food is the normal trigger. GLP-1 (glucagon-like peptide 1) is a hormone made by L-cells in the gut lining and released when you eat³. It tells the pancreas to release insulin, holds back glucagon, slows the gut and helps signal fullness³.

The catch is speed. An enzyme called DPP-4 inactivates GLP-1 so fast that much of it is cleared before it leaves the gut³. Semaglutide is built to resist this: its half-life is about 1 week, and it stays in the blood for 5 to 7 weeks after the last dose⁴.

That difference shows up in the results. In the STEP 1 trial of 1,961 adults with overweight or obesity and without diabetes, weekly semaglutide 2.4 mg plus lifestyle advice cut body weight by 14.9% over 68 weeks, against 2.4% with placebo⁷. Across trials, GLP-1 drugs reduce weight by 5% to 18%⁵. No food or diet trial has come close, and a 2025 joint advisory lists dietary modulation of your own GLP-1 as an area that still needs study⁵.

Four eating habits have raised GLP-1 in controlled human trials, mostly measured over a few hours after a single test meal^{1, 2, 8, 9}:

• A protein starter. In 15 adults with type 2 diabetes, 50 g of whey in water before a high-glycemic breakfast raised total GLP-1 by 141%, intact GLP-1 by 298% and insulin by 105%, and lowered glucose by 28% over 3 hours¹. A meta-analysis of 16 crossover trials in 244 people found that whey before meals lowered peak glucose by 1.4 mmol/L, but rated its GLP-1 effect as low certainty¹⁰. See our whey protein evidence page.
• Vegetables and protein before carbs. In 16 adults with type 2 diabetes, eating protein and vegetables 10 minutes before the carbohydrate raised GLP-1 and cut the glucose rise by 53% compared with carbohydrate first². In 16 healthy adults, the order vegetables, then meat, then rice gave the highest GLP-1 of 5 meal orders¹¹.
• Fermentable fiber. In a 10-person placebo-controlled trial, healthy adults given 16 g a day of prebiotic fiber for 2 weeks had higher GLP-1 and peptide YY after a meal, and less hunger, than the placebo group⁸. Prebiotic fibers such as inulin are what gut bacteria ferment. A lab-made inulin-propionate ester, built to deliver propionate to the colon, raised GLP-1 after a meal; over 24 weeks in 60 overweight adults, 10 g a day limited weight gain and abdominal fat gain better than plain inulin, the comparison group¹².
• Olive oil instead of butter. In 12 overweight adults with type 2 diabetes, a test meal with 80 g of olive oil gave a higher GLP-1 response than one with 100 g of butter⁹. Both were very high-fat meals, so the takeaway is the swap, not adding more fat.

These are small, short studies, mostly in people with diabetes, and they measured hormones and glucose, not weight. They support a way of eating that blunts post-meal glucose spikes, not a food list that works like a drug⁵.

Which foods mimic GLP-1?

None. GLP-1 is a hormone your own gut makes, so no food contains it; foods can only prompt the L-cells to release a little more³. Products sold as a "natural GLP-1" are making a claim about stimulation, not about supplying the hormone.

No. Several foods that are good for fullness or blood sugar lowered GLP-1 or left it unchanged in trials^{13, 14, 15, 16}:

• Psyllium. In 16 healthy adults, a meal with 23 g of psyllium and extra protein suppressed GLP-1 after eating, even though fiber meals lowered glucose and insulin¹³. See psyllium husk.
• Oat beta-glucan. In 33 healthy adults, 4 g at breakfast raised fullness and lowered early glucose, but GLP-1 was lower at 90 minutes and people ate no less at the next meal¹⁴.
• Avocado. In 26 overweight adults, adding avocado to lunch lowered the 3-hour GLP-1 response compared with an avocado-free meal¹⁵.
• Almonds. A meta-analysis of 9 trials in type 2 diabetes found no change in GLP-1, although almond diets lowered HbA1c and BMI¹⁶.

A systematic review of 26 trials in 831 people found prebiotic fiber raised fullness and lowered post-meal glucose, but its effects on GLP-1 and body weight were contradictory¹⁷. The lesson: judge foods by fullness, blood sugar and weight, not by a single hormone reading. Our fiber supplements page covers the outcomes that matter.

A few have some human data, but none has been shown to raise GLP-1 enough to cause drug-like weight loss^{18, 19, 20}:

• Berberine. A meta-analysis of 20 trials in 1,761 people found it lowered fasting glucose by 0.52 mmol/L and HbA1c by 4.48 mmol/mol¹⁸. Those trials measured glucose and insulin, not GLP-1. The GLP-1 link comes from reviews of mostly mechanistic work, which list berberine with tea, curcumin, cinnamon, soybean and resveratrol as possible influences on GLP-1 release²¹. See our berberine evidence page and berberine for blood sugar.
• Akkermansia. In a pilot trial of 40 overweight, insulin-resistant adults (32 finished), 3 months of pasteurized Akkermansia improved insulin sensitivity by 28.6% compared with placebo; weight fell 2.27 kg more than with placebo, which was not statistically significant¹⁹. In a 2026 trial of 142 adults with metabolic syndrome, the main insulin-sensitivity result was null; GLP-1 rose only in exploratory analyses²⁰. More on the Akkermansia page.
• Whey and fermentable fiber. These work as foods or powders taken before or with meals, as above^{1, 8}.

"Natural Ozempic" products are a different risk. The FDA warns that unapproved and compounded versions of semaglutide and tirzepatide skip its review for safety, effectiveness and quality, and it has received reports of hospitalizations linked to dosing errors with compounded semaglutide²². A supplement that claims to replace a prescribed GLP-1 drug has no trial behind that claim.

Supplements in this guide

• Whey Protein
• Inulin
• Psyllium Husk
• Fiber Supplements
• Berberine
• Akkermansia

Build each meal around protein, then add vegetables, fruit and whole grains as your appetite allows. The 2025 joint advisory from four obesity and nutrition societies names the main risks as stomach side effects, nutrient shortfalls from eating less, and loss of muscle and bone⁵.

Muscle mass is the big one. A 2026 systematic review of 35 randomized trials found a median of 28.3% of the weight lost on incretin drugs came from muscle-related tissue, although fat mass and visceral fat fell consistently²³. A 2026 clinical review proposes at least 1.2 g of protein per kg of body weight a day, up to 1.6 g/kg, spread as about 0.3 to 0.4 g/kg per meal, with resistance training²⁴. Those targets are for adults without chronic kidney disease; the same review calls for a different plan in kidney disease²⁴.

High-protein foods for GLP-1 users

Pick protein that is easy to eat in small portions and low in fat, which also suits the stomach-friendly advice below^{6, 24}:

• Lean animal protein: chicken or turkey breast, white fish, eggs, plain yogurt or skyr if dairy agrees with you.
• Plant protein: tofu, tempeh, lentils and beans, building up the beans slowly if they cause gas.
• Liquid options on low-appetite days: a whey or soy shake, or a protein-rich soup.

A multidisciplinary consensus on managing stomach side effects gives practical rules⁶:

• Do eat slowly, eat smaller portions more often, and stop as soon as you feel full.
• Do sip clear fluids through the day and choose water-rich foods such as soups and yogurt.
• Do bake, grill or boil rather than fry.
• Don't lie down straight after a meal or eat close to bedtime.
• Don't push through fullness to finish a plate.
• If nausea hits: plain crackers, apples, mint or ginger may ease it, eaten at least 30 minutes after your dose.

If you take semaglutide tablets, the label adds a food rule: take the tablet on an empty stomach with a little water, then wait at least 30 minutes before eating, drinking or taking other pills⁴.

• Do keep the tablet routine the same each morning.
• Don't take the tablet with coffee, juice or breakfast.

An expert panel that wrote 52 recommendations on this in 2026 noted that most rest on indirect evidence, because few trials have tested diets in people on these drugs²⁵. Treat these as sensible rules, not proven ones.

Limit the foods most likely to worsen nausea and fullness. Nausea and diarrhea were the most common side effects in STEP 1, and 4.5% of people on semaglutide stopped because of stomach problems, against 0.8% on placebo⁷. The consensus advises cutting back on⁶:

• Fatty, fried and heavy meals: choose bland, low-fat, easy-to-digest food instead.
• Sweet meals and rich sauces, dressings and spicy food.
• With diarrhea: alcohol, coffee, soft drinks, dairy, and sweeteners ending in "-ol" such as sorbitol and xylitol.
• High-fiber foods during diarrhea: beans, lentils, whole grains, cabbage and skinned fruit, reintroduced gradually once it settles.

If you have constipation instead, the same consensus advises enough fiber, plenty of water and more physical activity⁶.

Related conditions

• Obesity
• Type 2 Diabetes
• Prediabetes
• Frequent Nausea
• Chronic Constipation

Most people can use the food strategies here safely. These groups should check with a clinician first:

• People on insulin or sulfonylureas. Taking a GLP-1 drug with these raises the risk of low blood sugar, including severe episodes⁴. Berberine and whey starters also lower post-meal glucose^{18, 1}, so adding them to diabetes medicine needs a plan for monitoring.
• People taking other medicines. Berberine inhibits the liver enzymes CYP3A4 and CYP2D6, which clear many common drugs²⁶. Semaglutide slows stomach emptying, which may change how well other oral medicines are absorbed⁴.
• People with kidney disease. Vomiting and diarrhea on semaglutide can cause dehydration and kidney problems, more often in people with existing kidney impairment⁴. The protein targets in this guide are for adults without chronic kidney disease, so agree your own target with your kidney team²⁴.
• Pregnancy and breastfeeding. Stop semaglutide once pregnancy is recognized, or 2 months before a planned pregnancy, and breastfeeding is not recommended while taking the tablets⁴. Don't take berberine-containing herbs such as goldenseal while pregnant or breastfeeding, and never give them to infants: berberine can harm newborns²⁷.

Here is a sample day for an 80 kg adult aiming for about 1.2 g/kg of protein, or roughly 96 g, split into 25 to 30 g portions²⁴. Each meal puts protein and vegetables first and the starch last, the order that raised GLP-1 in trials^{2, 11}:

• Breakfast: 2 eggs and a small pot of plain yogurt first, then half a slice of whole-grain toast.
• Lunch: lentil and vegetable soup with grilled chicken, finishing with a small portion of rice.
• Snack: berries with yogurt, or a whey or soy shake on a low-appetite day.
• Dinner: baked white fish with roasted vegetables in a little olive oil, then a few boiled potatoes; or a tofu, broccoli and leafy greens stir-fry with brown rice eaten last.
• Through the day: water or other unsweetened drinks in small sips.

Not on a drug and simply want your own GLP-1 working for you? The same pattern applies: a protein starter, vegetables before starch, and fermentable prebiotic fiber^{1, 2, 8}. It supports appetite regulation, but expect modest results, not drug-sized ones^{7, 5}.

We searched PubMed and a research index for trials of foods, meal order, fiber, protein and supplements that measured GLP-1 in people, and for nutrition guidance for people on GLP-1 drugs. We read 27 study records and cited 24, alongside the semaglutide prescribing label on DailyMed, an FDA safety page and an NIH NCCIH fact sheet. A second reviewer checked every number against its source before publication. We prioritised meta-analyses, randomized trials and society guidance, and reported the trials where foods lowered or did not change GLP-1. Most food trials are small, last hours rather than months, and measure hormones rather than weight, so they cannot show that any food produces lasting weight loss. Researched October 2026.

1. Jakubowicz D, et al. Incretin, insulinotropic and glucose-lowering effects of whey protein pre-load in type 2 diabetes: a randomised clinical trial. Diabetologia. 2014;57(9):1807-11. doi:10.1007/s00125-014-3305-x
2. Shukla AP, et al. Carbohydrate-last meal pattern lowers postprandial glucose and insulin excursions in type 2 diabetes. BMJ Open Diabetes Res Care. 2017;5(1):e000440. doi:10.1136/bmjdrc-2017-000440
3. Holst JJ. The physiology of glucagon-like peptide 1. Physiol Rev. 2007;87(4):1409-39. doi:10.1152/physrev.00034.2006
4. U.S. National Library of Medicine, DailyMed. WEGOVY (semaglutide) injection and tablet: prescribing information (revised 6/2026). https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b
5. Mozaffarian D, et al. Nutritional priorities to support GLP-1 therapy for obesity: a joint Advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society. Am J Clin Nutr. 2025;122(1):344-367. doi:10.1016/j.ajcnut.2025.04.023
6. Gorgojo-Martínez JJ, et al. Clinical Recommendations to Manage Gastrointestinal Adverse Events in Patients Treated with Glp-1 Receptor Agonists: A Multidisciplinary Expert Consensus. J Clin Med. 2022;12(1). doi:10.3390/jcm12010145
7. Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021;384(11):989-1002. doi:10.1056/NEJMoa2032183
8. Cani PD, et al. Gut microbiota fermentation of prebiotics increases satietogenic and incretin gut peptide production with consequences for appetite sensation and glucose response after a meal. Am J Clin Nutr. 2009;90(5):1236-43. doi:10.3945/ajcn.2009.28095
9. Thomsen C, et al. Differential effects of saturated and monounsaturated fats on postprandial lipemia and glucagon-like peptide 1 responses in patients with type 2 diabetes. Am J Clin Nutr. 2003;77(3):605-11. doi:10.1093/ajcn/77.3.605
10. Smedegaard S, et al. Whey Protein Premeal Lowers Postprandial Glucose Concentrations in Adults Compared with Water-The Effect of Timing, Dose, and Metabolic Status: a Systematic Review and Meta-analysis. Am J Clin Nutr. 2023;118(2):391-405. doi:10.1016/j.ajcnut.2023.05.012
11. Sun L, et al. Postprandial glucose, insulin and incretin responses differ by test meal macronutrient ingestion sequence (PATTERN study). Clin Nutr. 2020;39(3):950-957. doi:10.1016/j.clnu.2019.04.001
12. Chambers ES, et al. Effects of targeted delivery of propionate to the human colon on appetite regulation, body weight maintenance and adiposity in overweight adults. Gut. 2015;64(11):1744-54. doi:10.1136/gutjnl-2014-307913
13. Karhunen LJ, et al. A psyllium fiber-enriched meal strongly attenuates postprandial gastrointestinal peptide release in healthy young adults. J Nutr. 2010;140(4):737-44. doi:10.3945/jn.109.115436 Our study summary.
14. Zaremba SMM, et al. Effects of oat β-glucan consumption at breakfast on ad libitum eating, appetite, glycemia, insulinemia and GLP-1 concentrations in healthy subjects. Appetite. 2018;128:197-204. doi:10.1016/j.appet.2018.06.019
15. Haddad E, et al. Postprandial gut hormone responses to Hass avocado meals and their association with visual analog scores in overweight adults: A randomized 3 × 3 crossover trial. Eat Behav. 2018;31:35-40. doi:10.1016/j.eatbeh.2018.08.001
16. Ojo O, et al. The Effects of Almonds on Gut Microbiota, Glycometabolism, and Inflammatory Markers in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomised Controlled Trials. Nutrients. 2021;13(10). doi:10.3390/nu13103377
17. Kellow NJ, et al. Metabolic benefits of dietary prebiotics in human subjects: a systematic review of randomised controlled trials. Br J Nutr. 2014;111(7):1147-61. doi:10.1017/S0007114513003607
18. Zhao JV, et al. Overall and Sex-Specific Effect of Berberine on Glycemic and Insulin-Related Traits: a Systematic Review and Meta-Analysis of Randomized Controlled Trials. J Nutr. 2023;153(10):2939-2950. doi:10.1016/j.tjnut.2023.08.016
19. Depommier C, et al. Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study. Nat Med. 2019;25(7):1096-1103. doi:10.1038/s41591-019-0495-2 Our study summary.
20. Suenaert P, et al. Effect of pasteurized Akkermansia muciniphila MucT on insulin sensitivity, body composition, and GLP-1 production in subjects with metabolic syndrome: impact of low baseline gut Akkermansia levels. Gut Microbes. 2026;18(1):2690689. doi:10.1080/19490976.2026.2690689 Our study summary.
21. Yaribeygi H, et al. Boosting GLP-1 by Natural Products. Adv Exp Med Biol. 2021;1328:513-522. doi:10.1007/978-3-030-73234-9_36
22. U.S. Food and Drug Administration. FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss. https://www.fda.gov/drugs/drug-alerts-and-statements/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss
23. Batsis JA, et al. Effect of Incretin-Based and Nonpharmacologic Weight Loss on Body Composition : A Systematic Review. Ann Intern Med. 2026;179(7):996-1013. doi:10.7326/ANNALS-25-00478
24. Arslan S. Medical nutrition in the glucagon-like peptide-1 (GLP-1) era: Protein strategies, micronutrient monitoring, and lean mass preservation. Clin Nutr ESPEN. 2026;73:103305. doi:10.1016/j.clnesp.2026.103305
25. Sievenpiper JL, et al. Nutritional and lifestyle supportive care recommendations for management of obesity with GLP-1 - based therapies: An expert consensus statement using a modified Delphi approach. Obes Pillars. 2026;17:100228. doi:10.1016/j.obpill.2025.100228
26. Bathaei P, et al. Effects of Berberis vulgaris, and its active constituent berberine on cytochrome P450: a review. Naunyn Schmiedebergs Arch Pharmacol. 2025;398(1):179-202. doi:10.1007/s00210-024-03326-x
27. National Center for Complementary and Integrative Health. Goldenseal: Usefulness and Safety. https://www.nccih.nih.gov/health/goldenseal